top of page


Lonza agrees to acquire five Merck KGaA US CDMO facilities to expand advanced biologics manufacturing
Lonza has agreed to acquire five US contract development and manufacturing facilities from Merck KGaA, strengthening its capabilities in advanced biologics, bioconjugation, viral vectors and specialised drug delivery.

nuaxia
Nov 52 min read


AGC Biologics expands dual-site pharmaceutical manufacturing contract to more than €500 million
AGC Biologics has expanded a long-term manufacturing agreement with an unnamed global pharmaceutical company to more than €500 million, adding six commercial biologics programmes at its Copenhagen facility.

nuaxia
Nov 42 min read


ABIONYX Pharma and OLON partner to prepare CER-001 for regulatory approval and commercial manufacturing
ABIONYX Pharma and OLON have established a strategic manufacturing partnership to support regulatory preparations and potential commercial production of CER-001.

nuaxia
Oct 82 min read


Alvotech and LOTTE Biologics sign US manufacturing partnership for multiple biosimilars
Alvotech and LOTTE Biologics have entered a US manufacturing agreement covering multiple antibody biosimilars for global supply.

nuaxia
Oct 71 min read
bottom of page